Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × abrysvo × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 5 Prednisone 5 Dexamethasone 5 Rituximab 4 Cisplatin 4 Carboplatin 4 enzalutamide 3 darolutamide 3 Vincristine 3 Tobacco Use Cessation Devices 3 Magnetic Resonance Spectroscopy 3 Letrozole 3 Injections 3 Hydromorphone 3 Bevacizumab 3 zanubrutinib 2 trametinib 2 ribociclib 2 pirtobrutinib 2 pembrolizumab 2 obinutuzumab 2 gadolinium ethoxybenzyl DTPA 2 enfortumab vedotin 2 dabrafenib 2 Watchful Waiting 2 Thalidomide 2 Standard of Care 2 Propofol 2 Paclitaxel 2 Oxaliplatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡